<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17681" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part indexed="no" book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Antibody Deficiency Disorder (Archived)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Justiz Vaillant</surname>
            <given-names>Angel A.</given-names>
          </name>
          <aff>University of the West Indies</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ramphul</surname>
            <given-names>Kamleshun</given-names>
          </name>
          <aff>Shanghai Jiao Tong University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Angel Justiz Vaillant declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kamleshun Ramphul declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>23</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17681.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Antibodies or immunoglobulins (Ig) play an important role in the immune system's mechanisms of defense. They fight off extracellular pathogens, for instance, bacteria, and can neutralize viruses when they are in the bloodstream and other body fluids. Normal individuals have 5 classes of immunoglobulins, which are IgM, IgG, IgA, IgD, and IgE, and immunoglobulin subclasses including IgG1, IgG2, IgG3, IgG4, IgA1, and IgA2.<xref ref-type="bibr" rid="article-17681.r1">[1]</xref> Sometimes an antibody deficiency disorder takes place. It can happen due to several causes, including a genetic absence of an important enzyme in B-cell development that renders immature B cells that are&#x000a0;unable to proliferate into mature Ig-producing B cells or may be caused when T lymphocytes do not signal B lymphocytes or are idiopathic.<xref ref-type="bibr" rid="article-17681.r2">[2]</xref><xref ref-type="bibr" rid="article-17681.r3">[3]</xref>&#x000a0;</p>
        <p>The most common antibody deficiency disorders<xref ref-type="bibr" rid="article-17681.r4">[4]</xref> include:</p>
        <list list-type="bullet">
          <list-item>
            <p>X-linked agammaglobulinemia (Bruton disease)<xref ref-type="bibr" rid="article-17681.r5">[5]</xref><xref ref-type="bibr" rid="article-17681.r6">[6]</xref></p>
          </list-item>
          <list-item>
            <p>Transient hypogammaglobulinemia of newborn</p>
          </list-item>
          <list-item>
            <p>Selective Ig immunodeficiencies, for example, IgA selective deficiency</p>
          </list-item>
          <list-item>
            <p>Super IgM syndrome</p>
          </list-item>
          <list-item>
            <p>Common variable immunodeficiency disorder<xref ref-type="bibr" rid="article-17681.r7">[7]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17681.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>
<bold>X-linked Agammaglobulinemia (Bruton Disease)</bold>
</p>
        <p>It is seen in boys. It is due to a failure of pre-B cells to differentiate into mature B lymphocytes as caused by a mutation in the gene that encodes for a tyrosine kinase protein needed for further differentiation.<xref ref-type="bibr" rid="article-17681.r4">[4]</xref><xref ref-type="bibr" rid="article-17681.r8">[8]</xref></p>
        <p>
<bold>Transient Hypogammaglobulinemia of Newborn</bold>
</p>
        <p>It is a physiological reaction of the body after the maternal antibody disappearance about 4 to 6 months of age. The child is susceptible to recurrent infections similar to those seen in X-linked agammaglobulinemia. Once the child's immune system matures and makes an antibody, this problem is corrected.<xref ref-type="bibr" rid="article-17681.r9">[9]</xref></p>
        <p>
<bold>Selective Ig Immunodeficiencies (IgA Selective Deficiency)</bold>
</p>
        <p>Normally, antibodies switch from IgM to other classes, including IgG and IgA. Sometimes there is malfunctioning in heavy-chain gene switching and causes this problem.<xref ref-type="bibr" rid="article-17681.r10">[10]</xref></p>
        <p>
<bold>Super IgM Syndrome</bold>
</p>
        <p>In this disease, the gene encoding the CD40 ligand on T cells is anomalous. That creates that B and T-lymphocyte cooperation in the immune response be compromised. The failure to interact with CD40 results in an inability of the B cell to switch from the production of IgM to the other classes of antibodies.<xref ref-type="bibr" rid="article-17681.r6">[6]</xref><xref ref-type="bibr" rid="article-17681.r11">[11]</xref></p>
        <p>
<bold>Common Variable Immunodeficiency Disorder</bold>
</p>
        <p>It expresses in the second or third decade of life or later. It has an unknown etiology.<xref ref-type="bibr" rid="article-17681.r12">[12]</xref></p>
      </sec>
      <sec id="article-17681.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Data have shown that the most prevalent immunodeficiency disorders are antibody deficiencies. These have been documented in many countries. For instance, in Singapore, 39 patients were diagnosed with immunodeficiency between 1990 and 2000, and 41% were antibody deficiency disorders.<xref ref-type="bibr" rid="article-17681.r13">[13]</xref>&#x000a0;Similarly, South Africa (51%),&#x000a0;<xref ref-type="bibr" rid="article-17681.r14">[14]</xref>,&#x000a0;Korea (53.3%)<xref ref-type="bibr" rid="article-17681.r15">[15]</xref>,&#x000a0;and Taiwan (46%)<xref ref-type="bibr" rid="article-17681.r16">[16]</xref>&#x000a0;reported this problem. In Denmark, medical records were reviewed and identified a CVID prevalence of 1:26,000, a peak in the fourth decade, and the frequency of respiratory infections was 98%. Other problems such as bronchiectasis (36%) and splenomegaly (22.4%) were reported.<xref ref-type="bibr" rid="article-17681.r7">[7]</xref></p>
      </sec>
      <sec id="article-17681.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Antibodies or immunoglobulins protect against extracellular microorganisms such as bacteria. They are produced by plasma cells, which are the product of the differentiation of mature B lymphocytes. Antibody deficiencies may occur due to lack of B-cells maturation, missing enzymes, or failure of T-cell stimulatory signals for appropriate&#x000a0;antibody production. In transient hypogammaglobulinemia of infancy, recurrent bacterial infections occur in children until their immune system matures.<xref ref-type="bibr" rid="article-17681.r17">[17]</xref><xref ref-type="bibr" rid="article-17681.r6">[6]</xref></p>
      </sec>
      <sec id="article-17681.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>X-linked agammaglobulinemia lacks germinal centers, and lymphoid architecture is grossly altered. Hyper-IgM syndrome results in elevated IgM concentrations along with IgG and IgA-selective immunodeficiency.<xref ref-type="bibr" rid="article-17681.r18">[18]</xref> The gallbladder in these patients shows alterations in submucosa that consists of cells with eccentric nuclei and pink-staining cytoplasm. These cells produce large quantities of IgM. Several immunodeficiencies can manifest lymph nodes with multiple B-cell follicles of variable sizes and proliferation centers when immunohistochemical staining for CD21 and CD79a is used.</p>
      </sec>
      <sec id="article-17681.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>In antibody immunodeficiency disorders, there is a history of:</p>
        <list list-type="bullet">
          <list-item>
            <p>Recurrent bacterial infections</p>
          </list-item>
          <list-item>
            <p>Fever</p>
          </list-item>
          <list-item>
            <p>Opportunistic infections</p>
          </list-item>
          <list-item>
            <p>Frequent use of antimicrobials without noticeable improvement<xref ref-type="bibr" rid="article-17681.r6">[6]</xref><xref ref-type="bibr" rid="article-17681.r19">[19]</xref></p>
          </list-item>
        </list>
        <p>&#x000a0;The physical findings<xref ref-type="bibr" rid="article-17681.r20">[20]</xref><xref ref-type="bibr" rid="article-17681.r21">[21]</xref><xref ref-type="bibr" rid="article-17681.r22">[22]</xref><xref ref-type="bibr" rid="article-17681.r23">[23]</xref><xref ref-type="bibr" rid="article-17681.r24">[24]</xref><xref ref-type="bibr" rid="article-17681.r25">[25]</xref>&#x000a0;include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Bacteremia</p>
          </list-item>
          <list-item>
            <p>Sinus pulmonary infections (e.g., pneumonia)</p>
          </list-item>
          <list-item>
            <p>Otitis media</p>
          </list-item>
          <list-item>
            <p>Meningitis</p>
          </list-item>
          <list-item>
            <p>Septicemia</p>
          </list-item>
          <list-item>
            <p>Arthritis</p>
          </list-item>
          <list-item>
            <p>A cough</p>
          </list-item>
          <list-item>
            <p>Malaise</p>
          </list-item>
          <list-item>
            <p>Intestinal malabsorption</p>
          </list-item>
          <list-item>
            <p>Bronchiectasis</p>
          </list-item>
          <list-item>
            <p>Recurrent tonsillitis</p>
          </list-item>
          <list-item>
            <p>A sore throat</p>
          </list-item>
          <list-item>
            <p>Purulent conjunctivitis</p>
          </list-item>
          <list-item>
            <p>Pyodermitis</p>
          </list-item>
          <list-item>
            <p>Failure to thrive&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Diarrhea &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Low set ears and facial dysmorphisms &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Recurrent abscess &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Septic shock &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Asthenia &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Anorexia &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Loss of weight&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Aphthous stomatitis</p>
          </list-item>
          <list-item>
            <p>Urinary sepsis</p>
          </list-item>
          <list-item>
            <p>Denture abnormalities and periodontitis</p>
          </list-item>
          <list-item>
            <p>Lymphoproliferative disease</p>
          </list-item>
          <list-item>
            <p>Sinus pulmonary infections</p>
          </list-item>
          <list-item>
            <p>Viral infections</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17681.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The immunological investigation of a patient with antibody deficiency includes the assessment of both B and T lymphocytes and other investigations as follow:<xref ref-type="bibr" rid="article-17681.r6">[6]</xref><xref ref-type="bibr" rid="article-17681.r20">[20]</xref><xref ref-type="bibr" rid="article-17681.r26">[26]</xref><xref ref-type="bibr" rid="article-17681.r27">[27]</xref>&#x000a0;</p>
        <p>
<bold>Quantitative Serum Immunoglobulins</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>IgG</p>
          </list-item>
          <list-item>
            <p>IgM</p>
          </list-item>
          <list-item>
            <p>IgA</p>
          </list-item>
        </list>
        <p>
<bold>IgG Sub-Classes</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>IgG1</p>
          </list-item>
          <list-item>
            <p>IgG2</p>
          </list-item>
          <list-item>
            <p>IgG3</p>
          </list-item>
          <list-item>
            <p>IgG4</p>
          </list-item>
        </list>
        <p>
<bold>B-cell Quantitative Assessment</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Levels of CD19</p>
          </list-item>
          <list-item>
            <p>Levels of CD20</p>
          </list-item>
          <list-item>
            <p>Levels of CD21</p>
          </list-item>
          <list-item>
            <p>Levels of CD81</p>
          </list-item>
          <list-item>
            <p>Levels of CD 225</p>
          </list-item>
        </list>
        <p>
<bold>Antibody Activity</bold>
</p>
        <p>
<italic toggle="yes">Detection of isohemagglutinins (IgM)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Anti-type A blood</p>
          </list-item>
          <list-item>
            <p>Anti-type B blood</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">IgG antibodies (post-exposure)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Rubella</p>
          </list-item>
          <list-item>
            <p>Measles</p>
          </list-item>
          <list-item>
            <p>Varicella-Zoster</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">IgG antibodies (post-immunization)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Tetanus toxoid</p>
          </list-item>
          <list-item>
            <p>Diphtheria toxoid</p>
          </list-item>
          <list-item>
            <p>Pneumococcal polysaccharide</p>
          </list-item>
          <list-item>
            <p>Polio</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Other assays</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Serum protein electrophoresis</p>
          </list-item>
        </list>
        <p>
<bold>Blood Lymphocyte T Subpopulations</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Total lymphocyte count</p>
          </list-item>
          <list-item>
            <p>T lymphocytes (CD3, CD4, and CD8)</p>
          </list-item>
          <list-item>
            <p>CD4/CD8 ratio</p>
          </list-item>
        </list>
        <p>
<bold>Lymphocyte Stimulation Assays </bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Phorbol ester and ionophore</p>
          </list-item>
          <list-item>
            <p>Phytohemagglutinin</p>
          </list-item>
          <list-item>
            <p>Antiserum to CD3</p>
          </list-item>
        </list>
        <p>
<bold>Phagocytic Function&#x000a0; </bold>
</p>
        <p>
<italic toggle="yes">Nitroblue tetrazolium (NBT) test (before and after stimulation with endotoxin)</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Unstimulated</p>
          </list-item>
          <list-item>
            <p>Stimulated</p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Neutrophil mobility</italic>
</p>
        <list list-type="bullet">
          <list-item>
            <p>In medium alone</p>
          </list-item>
          <list-item>
            <p>In the presence of chemoattractant</p>
          </list-item>
        </list>
        <p>
<bold>Microbiological Studies</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Stool (testing for bacterial infection)</p>
          </list-item>
          <list-item>
            <p>Sputum (bacterial culture)</p>
          </list-item>
          <list-item>
            <p>Cerebrospinal fluid (culture, chemistry, and histopathology)</p>
          </list-item>
          <list-item>
            <p>Blood culture</p>
          </list-item>
        </list>
        <p>
<bold>Levels of Cytokines</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>IL-1</p>
          </list-item>
          <list-item>
            <p>IL-2</p>
          </list-item>
          <list-item>
            <p>IL-4</p>
          </list-item>
          <list-item>
            <p>IL-5</p>
          </list-item>
          <list-item>
            <p>IL-6</p>
          </list-item>
          <list-item>
            <p>IL-13</p>
          </list-item>
          <list-item>
            <p>IL-17</p>
          </list-item>
          <list-item>
            <p>IL-22</p>
          </list-item>
        </list>
        <p>
<bold>Other Investigations&#x000a0; </bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Complete blood cell count&#x000a0;&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Blood chemistry</p>
          </list-item>
          <list-item>
            <p>Chest x-ray</p>
          </list-item>
          <list-item>
            <p>Diagnostic ultrasound</p>
          </list-item>
          <list-item>
            <p>CT scan</p>
          </list-item>
          <list-item>
            <p>Fluorescent in situ hybridization (FISH)</p>
          </list-item>
          <list-item>
            <p>DNA testing</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17681.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Antibody deficiency after diagnosis can be received intravenous immunoglobulin (IVIG) replacement therapy that is mostly IgG, but it may be enriched with IgM and IgA.<xref ref-type="bibr" rid="article-17681.r28">[28]</xref> It can be applied intravenously or intra-subcutaneously. Other medications used include antimicrobials such as broad-spectrum antibiotics and metronidazole, which may be used if anaerobic bacteria are suspected. Transfer factor is used if an underlying T-cell failure is suspected.<xref ref-type="bibr" rid="article-17681.r6">[6]</xref><xref ref-type="bibr" rid="article-17681.r22">[22]</xref></p>
        <p>Bone marrow transplantation (BMT) and gene therapy, which remain experimental, can be the solution for those deficiencies caused by genetic abnormalities, for instance, the use of BMT in X-linked agammaglobulinemia.<xref ref-type="bibr" rid="article-17681.r29">[29]</xref><xref ref-type="bibr" rid="article-17681.r30">[30]</xref><xref ref-type="bibr" rid="article-17681.r31">[31]</xref> In case of septic shock, treatment with steroids is reserved. Nutritional supplements can be administered, including vitamins A, C, E, and B6, iron, zinc, selenium, and copper.<xref ref-type="bibr" rid="article-17681.r32">[32]</xref></p>
      </sec>
      <sec id="article-17681.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The most important differential diagnosis includes&#x000a0;the following: X-linked agammaglobulinemia characterizes by recurrent bacterial infections in boys, and genetic studies may reveal the presence of&#x000a0;Bruton tyrosine kinase (BTK) mutations. Transient hypogammaglobulinemia of newborns presents in newborns above the age of 4 months and characterizes by recurrent pneumonia, meningitis, otitis media, and other problems that resemble Bruton disease. It is a physiological defect in the immune system caused by maternal IgG disappearance and corrected soon but requires treatment. In super-IgM syndrome, recurrent bacterial infections occur, but the cause of this illness is a mutation in the gene encoding for CD40 on T lymphocytes that causes a failure in T and B lymphocyte cooperation. Common variable immunodeficiency presents with recurrent bacterial infections, including sinopulmonary problems but later in life (second-fourth decade), and the diagnosis is made once all causes of immunodeficiency have been ruled out.<xref ref-type="bibr" rid="article-17681.r6">[6]</xref><xref ref-type="bibr" rid="article-17681.r7">[7]</xref><xref ref-type="bibr" rid="article-17681.r21">[21]</xref><xref ref-type="bibr" rid="article-17681.r33">[33]</xref></p>
        <p>Antibody deficiency may present in other diseases, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Multiple myelomas</p>
          </list-item>
          <list-item>
            <p>Burns</p>
          </list-item>
          <list-item>
            <p>Severely combined immunodeficiency disorders (SCID)</p>
          </list-item>
          <list-item>
            <p>Immunodeficiency with ataxia-telangiectasia</p>
          </list-item>
          <list-item>
            <p>DiGeorge syndrome</p>
          </list-item>
          <list-item>
            <p>Lymphomas</p>
          </list-item>
          <list-item>
            <p>Acute leukemia and other lymphoproliferative disorders&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Malnutrition</p>
          </list-item>
          <list-item>
            <p>Interleukin-12 receptor deficiency</p>
          </list-item>
          <list-item>
            <p>HIV/AIDS</p>
          </list-item>
          <list-item>
            <p>Use of immunosuppressors</p>
          </list-item>
          <list-item>
            <p>Systemic lupus erythematosus</p>
          </list-item>
          <list-item>
            <p>Bare leukocyte syndrome</p>
          </list-item>
          <list-item>
            <p>Organ transplantation recipient</p>
          </list-item>
          <list-item>
            <p>Sarcoidosis</p>
          </list-item>
          <list-item>
            <p>Amyloidosis</p>
          </list-item>
          <list-item>
            <p>Interferon-gamma (IFN-gamma) receptor deficiency</p>
          </list-item>
          <list-item>
            <p>Chronic granulomatous disease</p>
          </list-item>
          <list-item>
            <p>Wiskott-Aldrich syndrome</p>
          </list-item>
          <list-item>
            <p>Obesity</p>
          </list-item>
          <list-item>
            <p>Chronic renal failure</p>
          </list-item>
          <list-item>
            <p>C3 deficiency</p>
          </list-item>
          <list-item>
            <p>Toll-like receptor deficiency and other innate immune system-related deficiencies</p>
          </list-item>
          <list-item>
            <p>X-linked lymphoproliferative (XLP) syndrome</p>
          </list-item>
          <list-item>
            <p>Zinc deficiency</p>
          </list-item>
          <list-item>
            <p>TRAF3 adaptor molecule deficiency</p>
          </list-item>
          <list-item>
            <p>WHIM syndrome</p>
          </list-item>
          <list-item>
            <p>UNC93B deficiency</p>
          </list-item>
          <list-item>
            <p>Down syndrome</p>
          </list-item>
          <list-item>
            <p>Hemoglobinopathy</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17681.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Antibody deficiency disorders have a better prognosis if they can be treated with intravenous immunoglobulins (IVIG) or subcutaneous infusions once a week. The use of broad-spectrum antibiotics can improve life expectancy. X-linked agammaglobulinemia has a poor prognosis that can improve if bone marrow transplantation is successfully practiced. Transient hypogammaglobulinemia of infancy has the best prognosis because it is due to an immaturity of the neonate's immune system and is correct once their immunoglobulin synthesis starts.</p>
      </sec>
      <sec id="article-17681.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications due to recurrent and often severe infections are most common. Severe fulminant viral, bacterial, and fungal infections may occur in patients that cannot be treated with IVIG and may lead to septic shock.&#x000a0;</p>
      </sec>
      <sec id="article-17681.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>In chronic antibody deficiency disorders, patient education on compliance is crucial to prevent adverse outcomes.&#x000a0;</p>
      </sec>
      <sec id="article-17681.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <list list-type="bullet">
          <list-item>
            <p>Immune deficiency may be primary or secondary.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Primary occurs when certain cells or a part of the immune system does not work properly due to a genetic defect of the immune system.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Secondary occurs when the immune system works properly, but the function is compromised due to external factors (e.g., viral infections, treatment with immunosuppressors, and malnutrition).</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17681.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Antibody deficient&#x000a0;disorders may present soon after birth with recurrent infections. Because the management of these disorders is complex, they are best managed by an interprofessional team that includes an immunologist, pathologist, infectious disease nurse/specialist, pediatrician, and a geneticist. The key is to identify the antibody deficiency and initiate prompt treatment. These patients need lifelong monitoring as they are susceptible to a variety of infections. The nurse should educate the patient and caregivers on the importance of handwashing, maintenance of good personal hygiene, need for vaccination and follow-up. The nurse should assist the clinician in coordinating close follow-up care. A specialty-trained pharmacist should assist the clinician in the management of antibiotic therapy and IVIG and providing patient and caregiver education in regards to expected complications of therapy. an interprofessional approach to evaluating and treating antibody deficiency disorders will lead to the best outcomes. [Level 5]</p>
      </sec>
      <sec id="article-17681.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17681&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17681">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17681/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17681">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17681.s16">
        <title>References</title>
        <ref id="article-17681.r1">
          <label>1</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Justiz Vaillant</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Jamal</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ramphul</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Immunoglobulin</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>28</day>
            <pub-id pub-id-type="pmid">30035936</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cowan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Do</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Desjardins</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ramotar</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Corrales-Medina</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Cameron</surname>
                <given-names>DW</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of Hypogammaglobulinemia in Adult Invasive Pneumococcal Disease.</article-title>
            <source>Clin Infect Dis</source>
            <year>2018</year>
            <month>Feb</month>
            <day>01</day>
            <volume>66</volume>
            <issue>4</issue>
            <fpage>564</fpage>
            <page-range>564-569</page-range>
            <pub-id pub-id-type="pmid">29401274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gernez</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Maglione</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy.</article-title>
            <source>Transfusion</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>58 Suppl 3</volume>
            <issue>Suppl 3</issue>
            <fpage>3056</fpage>
            <page-range>3056-3064</page-range>
            <pub-id pub-id-type="pmid">30536429</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies</collab>
              <name>
                <surname>Notarangelo</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Fischer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Geha</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Casanova</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Chapel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Conley</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Etzioni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hammartr&#x000f6;m</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nonoyama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ochs</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Puck</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Roifman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Seger</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wedgwood</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Primary immunodeficiencies: 2009 update.</article-title>
            <source>J Allergy Clin Immunol</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>124</volume>
            <issue>6</issue>
            <fpage>1161</fpage>
            <page-range>1161-78</page-range>
            <pub-id pub-id-type="pmid">20004777</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Filion</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Taylor-Black</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Maglione</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Radigan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cunningham-Rundles</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Differentiation of Common Variable Immunodeficiency From IgG Deficiency.</article-title>
            <source>J Allergy Clin Immunol Pract</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>7</volume>
            <issue>4</issue>
            <fpage>1277</fpage>
            <page-range>1277-1284</page-range>
            <pub-id pub-id-type="pmid">30557717</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r6">
          <label>6</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Justiz Vaillant</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Qurie</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Immunodeficiency</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>6</month>
            <day>26</day>
            <pub-id pub-id-type="pmid">29763203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Westh</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mogensen</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Dalgaard</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Bernth Jensen</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Katzenstein</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Larsen</surname>
                <given-names>OD</given-names>
              </name>
              <name>
                <surname>Terpling</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Larsen</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Identification and Characterization of a Nationwide Danish Adult Common Variable Immunodeficiency Cohort.</article-title>
            <source>Scand J Immunol</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>85</volume>
            <issue>6</issue>
            <fpage>450</fpage>
            <page-range>450-461</page-range>
            <pub-id pub-id-type="pmid">28370285</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Geha</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Antibody deficiency syndromes and novel immunodeficiencies.</article-title>
            <source>Pediatr Infect Dis J</source>
            <year>1988</year>
            <month>May</month>
            <volume>7</volume>
            <issue>5 Suppl</issue>
            <fpage>S57</fpage>
            <page-range>S57-60</page-range>
            <pub-id pub-id-type="pmid">3041359</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moise</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nedelcu</surname>
                <given-names>FD</given-names>
              </name>
              <name>
                <surname>Toader</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Sora</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Tica</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ferastraoaru</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Constantinescu</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Primary immunodeficiencies of the B lymphocyte.</article-title>
            <source>J Med Life</source>
            <year>2010</year>
            <season>Jan-Mar</season>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>60</fpage>
            <page-range>60-3</page-range>
            <pub-id pub-id-type="pmid">20302197</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moschese</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Chini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Graziani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sgrulletti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gallo</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Di Matteo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Di Cesare</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cirillo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pession</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pignata</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Specchia</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Follow-up and outcome of symptomatic partial or absolute IgA deficiency in children.</article-title>
            <source>Eur J Pediatr</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>178</volume>
            <issue>1</issue>
            <fpage>51</fpage>
            <page-range>51-60</page-range>
            <pub-id pub-id-type="pmid">30269248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bazregari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Azizi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tavakol</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Asgardoon</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Kiaee</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tavakolinia</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Valizadeh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abolhassani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Aghamohammadi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of infectious and non-infectious complications in patients with primary immunodeficiency.</article-title>
            <source>Cent Eur J Immunol</source>
            <year>2017</year>
            <volume>42</volume>
            <issue>4</issue>
            <fpage>336</fpage>
            <page-range>336-341</page-range>
            <pub-id pub-id-type="pmid">29479289</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fomina</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Bobrikova</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>Sinyavkin</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Parshin</surname>
                <given-names>VV</given-names>
              </name>
            </person-group>
            <article-title>[Common variable immune deficiency in adults: focus on pulmonary complications].</article-title>
            <source>Ter Arkh</source>
            <year>2017</year>
            <volume>89</volume>
            <issue>12. Vyp. 2</issue>
            <fpage>211</fpage>
            <page-range>211-215</page-range>
            <pub-id pub-id-type="pmid">29488483</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lim</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Thong</surname>
                <given-names>BY</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Shek</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Lou</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Leong</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Chng</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>BW</given-names>
              </name>
            </person-group>
            <article-title>Primary immunodeficiency diseases in Singapore--the last 11 years.</article-title>
            <source>Singapore Med J</source>
            <year>2003</year>
            <month>Nov</month>
            <volume>44</volume>
            <issue>11</issue>
            <fpage>579</fpage>
            <page-range>579-86</page-range>
            <pub-id pub-id-type="pmid">15007498</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Naidoo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ungerer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pienaar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Eley</surname>
                <given-names>BS</given-names>
              </name>
            </person-group>
            <article-title>Primary immunodeficiencies: a 27-year review at a tertiary paediatric hospital in Cape Town, South Africa.</article-title>
            <source>J Clin Immunol</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>99</fpage>
            <page-range>99-105</page-range>
            <pub-id pub-id-type="pmid">20859665</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rhim</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Pai</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Son</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Hahn</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of primary immunodeficiency in Korea.</article-title>
            <source>J Korean Med Sci</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>27</volume>
            <issue>7</issue>
            <fpage>788</fpage>
            <page-range>788-93</page-range>
            <pub-id pub-id-type="pmid">22787376</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>WI</given-names>
              </name>
              <name>
                <surname>Kuo</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Distribution and clinical aspects of primary immunodeficiencies in a Taiwan pediatric tertiary hospital during a 20-year period.</article-title>
            <source>J Clin Immunol</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>162</fpage>
            <page-range>162-73</page-range>
            <pub-id pub-id-type="pmid">15821893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r17">
          <label>17</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Justiz Vaillant</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Qurie</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Interleukin</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2022</year>
            <month>8</month>
            <day>22</day>
            <pub-id pub-id-type="pmid">29763015</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferastraoaru</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gross</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rosenstreich</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Increased malignancy incidence in IgE deficient patients not due to concomitant Common Variable Immunodeficiency.</article-title>
            <source>Ann Allergy Asthma Immunol</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>119</volume>
            <issue>3</issue>
            <fpage>267</fpage>
            <page-range>267-273</page-range>
            <pub-id pub-id-type="pmid">28778662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r19">
          <label>19</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Justiz Vaillant</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Zito</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <chapter-title>Neutropenia</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2022</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">29939524</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoeger</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Serwas</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Boztug</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Human NF-&#x003ba;B1 Haploinsufficiency and Epstein-Barr Virus-Induced Disease-Molecular Mechanisms and Consequences.</article-title>
            <source>Front Immunol</source>
            <year>2017</year>
            <volume>8</volume>
            <fpage>1978</fpage>
            <pub-id pub-id-type="pmid">29403474</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Azizi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tavakol</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rafiemanesh</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kiaee</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Yazdani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Heydari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abouhamzeh</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Anvari</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mohammadikhajehdehi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sharifia</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bagheri</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mohammadi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Abolhassani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Aghamohammadi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Autoimmunity in a cohort of 471 patients with primary antibody deficiencies.</article-title>
            <source>Expert Rev Clin Immunol</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>13</volume>
            <issue>11</issue>
            <fpage>1099</fpage>
            <page-range>1099-1106</page-range>
            <pub-id pub-id-type="pmid">29019451</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Geng</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cameron</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Schulman</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>Primary immune deficiency diseases as unrecognized causes of chronic respiratory disease.</article-title>
            <source>Respir Med</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>132</volume>
            <fpage>181</fpage>
            <page-range>181-188</page-range>
            <pub-id pub-id-type="pmid">29229095</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yousefzadegan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tavakol</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Abolhassani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nadjafi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mansouri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yazdani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Azizi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Negahdari</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rezaei</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Aghamohammadi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Systematic investigation for underlying causes of recurrent infections in children: surveillance of primary immunodeficiency.</article-title>
            <source>Eur Ann Allergy Clin Immunol</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>50</volume>
            <issue>2</issue>
            <fpage>72</fpage>
            <page-range>72-80</page-range>
            <pub-id pub-id-type="pmid">29384110</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gompels</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Hodges</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lock</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Angus</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Larkin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chapel</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Spickett</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Misbah</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>JL</given-names>
              </name>
              <collab>Associated Study Group</collab>
            </person-group>
            <article-title>Lymphoproliferative disease in antibody deficiency: a multi-centre study.</article-title>
            <source>Clin Exp Immunol</source>
            <year>2003</year>
            <month>Nov</month>
            <volume>134</volume>
            <issue>2</issue>
            <fpage>314</fpage>
            <page-range>314-20</page-range>
            <pub-id pub-id-type="pmid">14616793</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dropulic</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>JI</given-names>
              </name>
            </person-group>
            <article-title>Severe viral infections and primary immunodeficiencies.</article-title>
            <source>Clin Infect Dis</source>
            <year>2011</year>
            <month>Nov</month>
            <volume>53</volume>
            <issue>9</issue>
            <fpage>897</fpage>
            <page-range>897-909</page-range>
            <pub-id pub-id-type="pmid">21960712</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r26">
          <label>26</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Taneja</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Muco</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chhabra</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Bruton Agammaglobulinemia</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>9</month>
            <day>4</day>
            <pub-id pub-id-type="pmid">28846295</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de la Morena</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Clinical Phenotypes of Hyper-IgM Syndromes.</article-title>
            <source>J Allergy Clin Immunol Pract</source>
            <year>2016</year>
            <season>Nov-Dec</season>
            <volume>4</volume>
            <issue>6</issue>
            <fpage>1023</fpage>
            <page-range>1023-1036</page-range>
            <pub-id pub-id-type="pmid">27836054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dhandha</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Siegfried</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Knutsen</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Treatment of selective antibody deficiency with IVIG resulting in decreased frequency of streptococcal infection and improvement of guttate psoriasis.</article-title>
            <source>Dermatol Online J</source>
            <year>2017</year>
            <month>Aug</month>
            <day>15</day>
            <volume>23</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">29469743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abu-Arja</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Chernin</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Abusin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Auletta</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cabral</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Egler</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ochs</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Torgerson</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Lopez-Guisa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hostoffer</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Tcheurekdjian</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cooke</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>Successful hematopoietic cell transplantation in a patient with X-linked agammaglobulinemia and acute myeloid leukemia.</article-title>
            <source>Pediatr Blood Cancer</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>62</volume>
            <issue>9</issue>
            <fpage>1674</fpage>
            <page-range>1674-6</page-range>
            <pub-id pub-id-type="pmid">25900577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verma</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Thaventhiran</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gathmann</surname>
                <given-names>B</given-names>
              </name>
              <collab>ESID Registry Working Party</collab>
              <name>
                <surname>Thaventhiran</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Grimbacher</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic management of primary immunodeficiency in older patients.</article-title>
            <source>Drugs Aging</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>30</volume>
            <issue>7</issue>
            <fpage>503</fpage>
            <page-range>503-12</page-range>
            <pub-id pub-id-type="pmid">23605785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Azizi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kiaee</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Yaslianifard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rafiemanesh</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mohammadikhajehdehi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mohammadi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Miresmaeeli</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Pour</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Poor Heravi</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Sharifi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yazdani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Abolhassani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Aghamohammadi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Mannose-Binding Lectin Protein Deficiency Among Patients with Primary Immunodeficiency Disease Receiving IVIG Therapy.</article-title>
            <source>Endocr Metab Immune Disord Drug Targets</source>
            <year>2018</year>
            <month>Feb</month>
            <day>13</day>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>175</fpage>
            <page-range>175-183</page-range>
            <pub-id pub-id-type="pmid">29119939</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agarwal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mayer</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency.</article-title>
            <source>Clin Gastroenterol Hepatol</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>11</volume>
            <issue>9</issue>
            <fpage>1050</fpage>
            <page-range>1050-63</page-range>
            <pub-id pub-id-type="pmid">23501398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17681.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Qiu</surname>
                <given-names>KY</given-names>
              </name>
              <name>
                <surname>Liao</surname>
                <given-names>XY</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fang</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>X-linked Hyper-IgM Syndrome: A Phenotype of Crohn's Disease with Hemophagocytic Lymphohistiocytosis.</article-title>
            <source>Pediatr Hematol Oncol</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>34</volume>
            <issue>8</issue>
            <fpage>428</fpage>
            <page-range>428-434</page-range>
            <pub-id pub-id-type="pmid">29303623</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
